参考文献/References:
[1] Lin YH,Hung CS,Tseng WYI,et al.Safety and feasibility of drug-eluting stent implantation at vertebral artery origin:the first case series in Asians[J].J Formos Med Assoc,2008,107(3):253-258.
[2] Markus HS,Harshfield EL,Compter A,et al.Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis[J].Lancet Neurol,2019,18(7):666-673.
[3] Li JZ,Hua Y,Needleman L,et al.Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting[J].J Neurointerv Surg,2019,11(6):574-578.
[4] Cai XL,Chen XP,Xiang YA,et al.Balloon-assisted angioplasty for the treatment of In-Stent restenosis after vertebral artery ostium stenting:experiences from one single center[J].Neurologist,2022,27(3):106-110.
[5] 闫宏伟,徐善才,张广,等.椎动脉起始部支架置入后再狭窄因素的研究进展[J].中国脑血管病杂志,2018,15(7):378-381.
[6] Naylor R,Rantner B,Ancetti S,et al.Editor's choice–European society for vascular surgery(ESVS)2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease[J].European Journal of Vascular and Endovascular Surgery,2023,65(1):7-111.
[7] 黄清海,刘建民.椎动脉起始部狭窄血管内治疗的困惑及发展趋势[J].中国脑血管病杂志,2011,8(1):1-3.
[8] Su H,Yu SY,Tian CL,et al.Effects of the vertebral artery ostium/subclavian artery angle on In-Stent restenosis after vertebral artery ostium stenting[J].Biomed Res Int,2021,2021:5527988.
[9] Song XW,Qiu HC,Wang S,et al.Hemodynamic and geometric risk factors for In-Stent restenosis in patients with intracranial atherosclerotic stenosis[J].Oxid Med Cell Longev,2022,2022:6951302.
[10] Iida M,Iida H,Takenaka M,et al.Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats[J].J Anesth,2012,26(6):928-931.
[11] 杨烁,于波.吸烟与他汀类药物疗效在冠状动脉粥样硬化中的相互影响[J].心血管康复医学杂志,2021,30(3):366-370.
[12] Sorin U,Mikhailidis DP,Maria-Corina S,et al.The effect of statins on cardiovascular outcomes by smoking status:a systematic review and meta-analysis of randomized controlled trials[J].Pharmacol Res,2017,122:105-117.
[13] Taylor RA,Siddiq F,Suri MFK,et al.Risk factors for in-stent restenosis after vertebral ostium stenting[J].J Endovasc Ther,2008,15(2):203-212.
[14] Xu J,Viscoli CM,Ford GA,et al.A diagnostic score for insulin resistance in nondiabetic patients with ischemic stroke or transient ischemic attack[J].J Stroke Cerebrovasc Dis,2016,25(7):1705-1712.
[15] Fiorentino TV,Marini MA,Succurro E,et al.Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage[J].BMJ Open Diabetes Res Care,2019,7(1):e000911.
[16] Sevuk U,Bahadir MV,Altindag R,et al.Relationship between thyroid function and carotid artery plaque ulceration[J].Acta Neurol Belg,2015,115(4):581-587.
[17] 陈玲玲,李波.甘油三酯葡萄糖指数与冠心病患者经皮冠状动脉介入术后发生支架内再狭窄的关联性研究[J].中国临床新医学,2022,15(7):631-635.
[18] 王力锋,何晓芬,周子杰.椎动脉狭窄和冠状动脉狭窄之间的相关性研究[J].中国医药,2021,16(4):558-561.
[19] Poddar R.Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke[J].Exp Neurol,2021,336:113541.
[20] Shiran A,Remer E,Asmer I,et al.Association of vitamin B12 deficiency with homozygosity of the TT MTHFR C677T genotype, hyperhomocysteinemia, and endothelial cell dysfunction[J].Isr Med Assoc J,2015,17(5):288-292.
[21] Hu F,Yu SC,Li J,et al.Association between hyperhomocysteinemia combined with metabolic syndrome and higher prevalence of stroke in Chinese adults who have elevated blood pressure[J].Med Sci Monit,2022,28:e934100.
[22] 汪洋,吴磊,尹博文,等.高同型半胱氨酸血症与颅内动脉狭窄支架置入术后再发症状性脑梗死的相关性研究[J].实用临床医药杂志,2018,22(17):15-17.
[23] Haribabu A,Reddy VS,Pallavi C,et al.Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism[J].Endocrine,2013,44(1):152-157.
[24] 陆敏艳,戚志强,何庆芳,等.亚临床甲状腺功能减退症与急性缺血性卒中患者颈动脉粥样硬化的相关性[J].国际脑血管病杂志,2018,26(12):881-886.
[25] Boekholdt SM,Titan SM,Wiersinga WM,et al.Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study[J].Clin Endocrinol(Oxf),2010,72(3):404-410.
[26] 姜海波,王小姗,曹辉,等.支架置入术治疗椎动脉起始段狭窄的临床疗效及术后支架内再狭窄的影响因素分析[J].现代生物医学进展,2020,20(22):4274-4278.
[27] Kang K,Lee K,Chung SH.The triglyceride:high-density lipoprotein-cholesterol ratio and steno-occlusive disease in the intracranial arteries[J].J Thromb Thrombolysis,2011,32(1):103-109.
[28] 王薇,赵冬,孙佳艺,等.中国11省市队列人群危险因素与不同类型心血管病发病危险的比较[J].中华心血管病杂志,2006(12):1133-1137.
[29] 逄锦晶,宋丽艳,徐丽红,等.缺血性卒中患者颅内外动脉狭窄与高血压、糖尿病的研究[J].中国卒中杂志,2018,13(3):242-246.
[30] 王晓莉,张维文,张方圆,等.氯吡格雷抵抗对椎动脉狭窄支架术后再狭窄的影响[J].中国临床神经外科杂志,2022,27(7):585-586.
[31] Yi X,Wang Y,Lin J,et al.Interaction of CYP2C19,P2Y12,and GPIIIa variants associates with efficacy of clopidogrel and adverse events on patients with ischemic stroke[J].Clin Appl Thromb Hemost,2017,23(7):761-768.
[32] 蔡皓伟,李春月.CYP2C19基因多态性对老年患者椎动脉支架术后不良事件发生情况的影响[J].中华老年多器官疾病杂志,2022,21(3):204-207.
[33] 张红霞,郭亚珂,张申,等.血浆Lp-PLA2,D-二聚体及血小板活性指标与脑梗死后神经功能缺损的关系分析[J].解放军预防杂志志,2019,37(06):171-172.
[34] Maciejewski DR,Pieniazek P,Tekieli L,et al.Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting[J].Postepy Kardiol Interwencyjnej,2019,15(3):328-337.
[35] Zhang R,Tao ZX,Gong J,et al.Albumin to globulin ratio was associated with in-stent restenosis and revascularization events after percutaneous coronary intervention[J].Clin Transl Sci,2022,15(5):1187-1195.
[36] 柳文科,范雪娟,杨霄鹏.球扩式支架与自膨式支架治疗症状性颅内动脉狭窄的临床效果对比[J].河南医学研究,2016,25(5):856-857.
[37] Zheng D,Mingyue Z,Wei S,et al.The incidence and risk factors of in-stent restenosis for vertebrobasilar artery stenting[J].World Neurosurg,2018,110:e937-e941.
[38] Chen WH,Huang F,Li M,et al.Incidence and predictors of the in-stent restenosis after vertebral artery ostium stenting[J].J Stroke Cerebrovasc Dis,2018,27(11):3030-3035.
[39] Stayman AN,Nogueira RG,Gupta R.A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis[J].Stroke,2011,42(8):2212-2216.
[40] Li MKA,Tsang ACO,Tsang FCP,et al.Long-term risk of in-stent restenosis and stent fracture for extracranial vertebral artery stenting[J].Clin Neuroradiol,2019,29(4):701-706.
[41] Derdeyn CP,Fiorella D,Lynn MJ,et al.Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the sammpris trial(stenting and aggressive medical management for the prevention of recurrent stroke in intracranial stenosis)[J].Stroke,2017,48(6):1501-1506.